Prestige Wealth Management Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.71M | Sell |
36,409
-685
| -2% | -$80.2K | 0.85% | 27 |
|
|
2026
Q1 | $4.49M | Buy |
37,094
+420
| +1% | +$48.5K | 0.88% | 23 |
|
|
2025
Q4 | $3.89M | Buy |
36,674
+6,909
| +23% | +$649K | 0.74% | 28 |
|
|
2025
Q3 | $2.52M | Sell |
29,765
-105
| -0.4% | -$8.65K | 0.49% | 39 |
|
|
2025
Q2 | $2.39M | Sell |
29,870
-1,968
| -6% | -$156K | 0.49% | 38 |
|
|
2025
Q1 | $2.88M | Buy |
31,838
+487
| +2% | +$45.5K | 0.62% | 28 |
|
|
2024
Q4 | $3.14M | Sell |
31,351
-158
| -0.5% | -$16.3K | 0.65% | 32 |
|
|
2024
Q3 | $3.6M | Buy |
31,509
+710
| +2% | +$84.4K | 0.74% | 27 |
|
|
2024
Q2 | $3.84M | Buy |
30,799
+454
| +1% | +$58.5K | 0.83% | 26 |
|
|
2024
Q1 | $4.03M | Sell |
30,345
-679
| -2% | -$83.7K | 0.87% | 25 |
|
|
2023
Q4 | $3.41M | Sell |
31,024
-760
| -2% | -$78.9K | 0.77% | 27 |
|
|
2023
Q3 | $3.3M | Sell |
31,784
-634
| -2% | -$68.3K | 0.81% | 24 |
|
|
2023
Q2 | $3.76M | Sell |
32,418
-6,087
| -16% | -$691K | 0.89% | 21 |
|
|
2023
Q1 | $4.12M | Buy |
38,505
+7,020
| +22% | +$758K | 1.04% | 19 |
|
|
2022
Q4 | $3.52M | Sell |
31,485
-6,197
| -16% | -$633K | 0.92% | 22 |
|
|
2022
Q3 | $3.27M | Buy |
37,682
+819
| +2% | +$73.1K | 0.92% | 22 |
|
|
2022
Q2 | $3.39M | Sell |
36,863
-2,099
| -5% | -$186K | 0.92% | 22 |
|
|
2022
Q1 | $3.2M | Buy |
38,962
+5,862
| +18% | +$462K | 0.79% | 23 |
|
|
2021
Q4 | $2.54M | Buy |
33,100
+2,285
| +7% | +$182K | 0.61% | 30 |
|
|
2021
Q3 | $2.31M | Buy |
30,815
+689
| +2% | +$52.4K | 0.59% | 30 |
|
|
2021
Q2 | $2.34M | Sell |
30,126
-31
| -0.1% | -$2.31K | 0.62% | 29 |
|
|
2021
Q1 | $2.22M | Sell |
30,157
-580
| -2% | -$42.8K | 0.61% | 29 |
|
|
2020
Q4 | $2.4M | Sell |
30,737
-547
| -2% | -$41.8K | 0.66% | 28 |
|
|
2020
Q3 | $2.48M | Sell |
31,284
-247
| -0.8% | -$19.3K | 0.75% | 21 |
|
|
2020
Q2 | $2.33M | Sell |
31,531
-713
| -2% | -$53.7K | 0.82% | 21 |
|
|
2020
Q1 | $2.37M | Sell |
32,244
-6,454
| -17% | -$507K | 1% | 16 |
|
|
2019
Q4 | $3.36M | Sell |
38,698
-346
| -0.9% | -$28.4K | 1.84% | 10 |
|
|
2019
Q3 | $3.14M | Sell |
39,044
-28
| -0.1% | -$2.24K | 1.84% | 8 |
|
|
2019
Q2 | $3.13M | Sell |
39,072
-673
| -2% | -$51.5K | 1.89% | 8 |
|
|
2019
Q1 | $3.15M | Buy |
39,745
+508
| +1% | +$38K | 1.94% | 8 |
|
|
2018
Q4 | $2.86M | Buy |
+39,237
| New | +$2.77M | 2.11% | 9 |
|
Other funds holding MRK
Prestige Wealth Management Group's MRK Position: Q2 2026 in Review
Prestige Wealth Management Group reduced its Merck (MRK) stake by 1.8% in Q2 2026, selling an estimated $80.2K and leaving 36,409 shares worth $4.71M. The position accounts for 0.85% of the portfolio, ranked #27.
Prestige Wealth Management Group first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Prestige Wealth Management Group held 36,409 shares of Merck worth $4.71M as of Q2 2026.
- Prestige Wealth Management Group sold 685 Merck shares in Q2 2026, an estimated $80.2K.
- Merck made up 0.85% of Prestige Wealth Management Group's portfolio in Q2 2026, its #27 holding.
- Prestige Wealth Management Group first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.